KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 129 filers reported holding KYMERA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $13,799,924 | -23.8% | 462,309 | +2.6% | 0.00% | -33.3% |
Q1 2024 | $18,110,823 | +5.4% | 450,518 | -33.2% | 0.00% | 0.0% |
Q4 2023 | $17,176,716 | +503.7% | 674,655 | +229.6% | 0.00% | +200.0% |
Q3 2023 | $2,845,441 | -63.8% | 204,708 | -40.1% | 0.00% | -50.0% |
Q2 2023 | $7,852,120 | -10.7% | 341,545 | +15.1% | 0.00% | 0.0% |
Q1 2023 | $8,795,458 | +4.3% | 296,843 | -12.2% | 0.00% | 0.0% |
Q4 2022 | $8,434,733 | +114955.7% | 337,930 | +0.3% | 0.00% | 0.0% |
Q3 2022 | $7,331 | +34.3% | 336,759 | +21.5% | 0.00% | +100.0% |
Q2 2022 | $5,459 | -99.9% | 277,264 | +13.7% | 0.00% | -50.0% |
Q1 2022 | $10,323,000 | -39.3% | 243,926 | -8.9% | 0.00% | -33.3% |
Q4 2021 | $17,002,000 | +60.6% | 267,790 | +48.6% | 0.00% | +50.0% |
Q3 2021 | $10,585,000 | +172.7% | 180,207 | +125.3% | 0.00% | +100.0% |
Q2 2021 | $3,881,000 | +589.3% | 80,003 | +451.9% | 0.00% | – |
Q1 2021 | $563,000 | -67.5% | 14,496 | -48.1% | 0.00% | – |
Q4 2020 | $1,732,000 | -63.7% | 27,930 | -81.1% | 0.00% | -100.0% |
Q3 2020 | $4,773,000 | – | 147,738 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 5,984,736 | $149,379,011 | 17.99% |
Aquilo Capital Management, LLC | 629,411 | $15,710,099 | 5.90% |
BVF INC/IL | 4,692,604 | $117,127,396 | 4.94% |
Artal Group S.A. | 2,000,000 | $49,920 | 2.79% |
Redmile Group, LLC | 2,673,837 | $66,738,972 | 2.73% |
Avoro Capital Advisors LLC | 3,850,000 | $96,096,000 | 1.44% |
Deer Management Co. LLC | 615,895 | $15,372,739 | 1.42% |
AtonRa Partners | 27,125 | $677,040 | 0.86% |
Rock Springs Capital Management LP | 1,227,779 | $30,645,364 | 0.74% |
EcoR1 Capital, LLC | 796,093 | $19,870,481 | 0.60% |